Clincosm LogoSign in Get a demo

lymphoma

Showing 1 - 25 of 1,641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FUR to Quantify Tumor Glucose Consumption in Oncologic PET

Not yet recruiting
  • Lung Cancer
  • Lymphoma
  • FDG PET/CT
  • Maastricht, Limburg, Netherlands
    Academisch ziekenhuis Maastricht
Jan 31, 2023

Assessing the Presence of CT-DNA in Lymphoma Associated HLH

Not yet recruiting
  • Lymphoma
  • Haemophagocytic Lymphohistiocytosis
    • (no location specified)
    Jan 25, 2023

    Solid Tumors, Adult, Multiple Myeloma, Lymphoma Trial in San Antonio (VP301)

    Recruiting
    • Solid Tumors, Adult
    • +2 more
    • San Antonio, Texas
      NEXT Oncology
    Jan 16, 2023

    Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

    Recruiting
    • Hematologic Malignancy
    • +4 more
    • Palliative Care
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 24, 2023

    Lymphoma, Multiple Myeloma Trial in Nagoya, Koto, Yamagata (TTI-622)

    Recruiting
    • Lymphoma
    • Multiple Myeloma
    • Nagoya, Aichi, Japan
    • +2 more
    Jan 20, 2023

    Lymphoma Trial (Epcoritamab)

    Available
    • Lymphoma
    • (no location specified)
    Jan 13, 2023

    Bone Marrow Cancer, Leukemia, Lymphoma Trial in Philadelphia (Virtual reality, Environmental changes)

    Enrolling by invitation
    • Bone Marrow Cancer
    • +4 more
    • Virtual reality
    • Environmental changes
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jan 9, 2023

    Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

    Not yet recruiting
    • Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2023

    Lymphoma, Autologous Hematopoietic Stem Cell Transplantation Trial in Xi'an (Improved BEAM regimen)

    Not yet recruiting
    • Lymphoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • Improved BEAM regimen
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Dec 26, 2022

    Penpulimab in Maintenance Therapy in Lymphoma

    Not yet recruiting
    • Lymphoma
    • (no location specified)
    Dec 25, 2022

    Lymphoma Trial in Houston (cell-free DNA)

    Not yet recruiting
    • Lymphoma
    • cell-free DNA
    • Houston, Texas
      MD Anderson Cancer Center
    Dec 22, 2022

    Lymphoma Trial in China (Brentuximab Vedotin, Cyclophosphamide, Doxorubicin)

    Not yet recruiting
    • Lymphoma
    • Brentuximab Vedotin
    • +3 more
    • Beijing, China
    • +15 more
    Jan 4, 2023

    Immunodeficiency, Immunosuppression, HIV Trial in La Jolla (Access to Cue Health COVID-19 Remote testing and treatment for

    Recruiting
    • Immunodeficiency
    • +8 more
    • Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
    • La Jolla, California
      Scripps Research
    Dec 22, 2022

    Collecting Blood and Tissue Sample Donations for Research for

    Not yet recruiting
    • Anal Carcinoma
    • +11 more
    • Biospecimen Collection
    • (no location specified)
    Dec 21, 2022

    Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • CAR-T Autologous T cell injection
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Dec 2, 2022

    A Single-Site Tissue Repository Providing Annotated Biospecimens

    Recruiting
    • Age-Related Macular Degeneration
    • +46 more
    • Specimen sample
    • Waltham, Massachusetts
      Sanguine Biosciences
    Nov 22, 2022

    Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

    Recruiting
    • Solid Tumor, Adult
    • +6 more
    • TP53-EphA-2-CAR-DC
    • +3 more
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinsese PLA Gereral Hospital
    Nov 29, 2022

    Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

    Not yet recruiting
    • Hemophagocytic Lymphohistiocytoses
    • Lymphoma
    • cytokine
    • Beijing, Beijing, China
      Zhao Wang
    Oct 27, 2022

    PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow

    Not yet recruiting
    • Lymphoma
    • positron emission tomography for exclusion of bone marrow infiltration in lymphoma
    • (no location specified)
    Oct 28, 2022

    Advanced Solid Tumor, Lung Cancer, Liver Cancer Trial in China (T3011)

    Recruiting
    • Advanced Solid Tumor
    • +4 more
    • T3011
    • Bengbu, Anhui, China
    • +6 more
    Oct 24, 2022

    Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

    Not yet recruiting
    • Pediatric Cancer
    • +11 more
    • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
    • Milwaukee, Wisconsin
      Children's Wisconsin
    Sep 14, 2022

    Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

    Recruiting
    • Lymphoma
    • +4 more
    • Pharmacokinetics
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 12, 2022

    Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

    Recruiting
    • Lymphoma
    • Multiple Myeloma
    • Hangzhou, Zhejiang, China
    • +6 more
    Sep 7, 2022

    Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

    Recruiting
    • Lymphoma
    • +3 more
    • Los Angeles, California
    • +48 more
    Aug 19, 2022

    Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

    Recruiting
    • Lymphoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022